IP Library Granted Patent US 9,528,106
Granted Patent B2
US 9,528,106 · App. 13/733,473 · Granted Dec 27, 2016

In vitro sorting method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,528,106
App. No.
13/733,473
Granted
Dec 27, 2016
Kind
B2
Abstract

The invention describes a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising of the steps of: (a) compartmentalizing genetic elements into microcapsules; (b) expressing the genetic elements to produce their respective gene products within the microcapsules; (c) sorting the genetic elements which produce the gene product having a desired activity. The invention enables the in vitro evolution of nucleic acids by repeated mutagenesis and iterative applications of the method of the invention.

Claims (31)

1. A method for isolating one or more genetic elements encoding a gene product having a desired catalytic activity, comprising the steps of:

(a) compartmentalising the genetic elements into microcapsules;

(b) expressing the genetic elements to produce their respective gene products within the microcapsules; and

(c) sorting the genetic elements which produce gene product(s) having the desired catalytic activity,

wherein the desired catalytic activity of the gene product results, directly or indirectly, in the enzymatic modification of the genetic element encoding the gene product or the microcapsule containing it to enable the isolation of the genetic element, and wherein the gene product having the desired catalytic activity induces a change in the microcapsule which, when detected, triggers the modification of the genetic element within the compartment to enable the isolation of the genetic element.

2. A method for isolating one or more genetic elements encoding a gene product having a desired catalytic activity, comprising the steps of:

(a) compartmentalising the genetic elements into microcapsules;

(b) expressing the genetic elements to produce their respective gene products within the microcapsules; and

(c) sorting the genetic elements which produce gene product(s) having the desired catalytic activity, wherein the genetic element encodes a dihydrofolate reductase gene.

3. A method according to claim 2 , wherein the genetic element encodes a bacterial dihydrofolate reductase gene.

4. A method for isolating one or more genetic elements encoding a gene product having a desired catalytic activity, comprising the steps of:

(a) compartmentalising the genetic elements into microcapsules;

(b) expressing the genetic elements to produce their respective gene products within the microcapsules; and

(c) sorting the genetic elements which produce gene product(s) having the desired catalytic activity, wherein the genetic element is linked to a plurality of substrate molecules.

5. A method for isolating one or more genetic elements encoding a gene product having a desired catalytic activity, comprising the steps of:

(a) compartmentalising the genetic elements into microcapsules;

(b) expressing the genetic elements to produce their respective gene products within the microcapsules; and

(c) sorting the genetic elements which produce gene product(s) having the desired catalytic activity, wherein the isolating is by affinity purification of said genetic elements.

6. A method for isolating one or more genetic elements encoding a gene product having a desired catalytic activity, comprising the steps of:

(a) compartmentalising the genetic elements into microcapsules;

(b) expressing the genetic elements to produce their respective gene products within the microcapsules; and

(c) sorting the genetic elements which produce gene product(s) having the desired catalytic activity, wherein the isolating is by affinity purification using an antibody that binds specifically to an antigen in the gene product.

7. A method for isolating one or more genetic elements encoding a gene product having a desired catalytic activity, comprising the steps of:

(a) compartmentalising the genetic elements into microcapsules;

(b) expressing the genetic elements to produce their respective gene products within the microcapsules; and

(c) sorting the genetic elements which produce gene product(s) having the desired catalytic activity, wherein the microcapsules are formed from an emulsion comprising a heterogenous system of a first immiscible liquid phase and a second immiscible liquid phase, wherein the first immiscible liquid phase is dispersed in the second immiscible liquid phase as droplets of microscopic or colloidal size.

8. A method according to claim 7 , wherein the emulsion has water as the first immiscible liquid phase present in the form of finely divided droplets and the second immiscible liquid phase is a hydrophobic, immiscible liquid phase.

9. A method according to claim 7 , wherein said heterogeneous system is a water-in-oil emulsion.

10. A method according to claim 9 , wherein said emulsion further comprises at least one surfactant.

11. A method according to claim 10 , wherein said at least one surfactant is an anionic surfactant.

12. A method according to claim 11 , wherein said at least one surfactant is selected from the group consisting of sodium cholate and sodium taurocholate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2018
From: MEDICAL RESEARCH COUNCIL
To: UNITED KINGDOM RESEARCH AND INNOVATION
Reel/Frame 046469/0108 →